William Harvey Research Institute, Barts and The London Medical School, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
Curr Opin Pharmacol. 2009 Aug;9(4):521-8. doi: 10.1016/j.coph.2009.04.007. Epub 2009 May 27.
Studies over the last decade have provided us with a wealth of evidence showing that Annexin-1 is a homeostatic endogenous anti-inflammatory mediator of the innate immune system. However, as in Robert Louis Stevenson's novel 'The Strange Case of Dr Jekyll and Mr Hyde', recent investigations on the role of this protein in the adaptive immune response have revealed a previous unknown 'dark side' as positive modulator of T cell activation. This review will be focusing on these recent findings providing further evidences for the promising therapeutic potential of drugs targeting Annexin-1.
过去十年的研究为我们提供了大量证据,表明膜联蛋白-1 是先天免疫系统的一种内源性稳态抗炎介质。然而,就像罗伯特·路易斯·史蒂文森的小说《化身博士》一样,最近对该蛋白在适应性免疫反应中的作用的研究揭示了其以前未知的“另一面”,即正向调节 T 细胞激活。本综述将重点介绍这些最新发现,为靶向膜联蛋白-1 的药物提供有前景的治疗潜力的进一步证据。